TY - JOUR
T1 - "Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture"
AU - Menna, Cecilia
AU - De Falco, Elena
AU - Pacini, Luca
AU - Scafetta, Gaia
AU - Ruggieri, Paola
AU - Puca, Rosa
AU - Petrozza, Vincenzo
AU - Ciccone, Anna Maria
AU - Rendina, Erino Angelo
AU - Calogero, Antonella
AU - Ibrahim, Mohsen
N1 - Funding Information:
This work was financially supported by the University of Rome “Sapienza.”
PY - 2014/1
Y1 - 2014/1
N2 - Fetal lung adenocarcinoma (FLAC) is a rare variant of lung adenocarcinoma. Studies regarding FLAC have been based only on histopathological observations, thus representative in vitro models of FLAC cultures are unavailable. We have established and characterized a human primary FLAC cell culture, exploring its biology, chemosensitivity, and migration. FLAC cells and specimen showed significant upregulation of VEGF165 and HIF-1α mRNA levels. This observation was confirmed by in vitro chemosensitivity and migration assay, showing that only Axitinib was comparable to Cisplatin treatment. We provide a suitable in vitro model to further investigate the nature of this rare type of cancer.
AB - Fetal lung adenocarcinoma (FLAC) is a rare variant of lung adenocarcinoma. Studies regarding FLAC have been based only on histopathological observations, thus representative in vitro models of FLAC cultures are unavailable. We have established and characterized a human primary FLAC cell culture, exploring its biology, chemosensitivity, and migration. FLAC cells and specimen showed significant upregulation of VEGF165 and HIF-1α mRNA levels. This observation was confirmed by in vitro chemosensitivity and migration assay, showing that only Axitinib was comparable to Cisplatin treatment. We provide a suitable in vitro model to further investigate the nature of this rare type of cancer.
KW - Antineoplastic drugs
KW - Axitinib
KW - Cancer primary cell cultures
KW - Fetal lung adenocarcinoma
KW - Lung adenocarcinoma
KW - Vascular endothelial growth factor
UR - http://www.scopus.com/inward/record.url?scp=84891525458&partnerID=8YFLogxK
U2 - 10.3109/07357907.2013.861472
DO - 10.3109/07357907.2013.861472
M3 - Article
C2 - 24380379
AN - SCOPUS:84891525458
SN - 0735-7907
VL - 32
SP - 13
EP - 21
JO - Cancer Investigation
JF - Cancer Investigation
IS - 1
ER -